G1 Therapeutics has contributed exciting new data that represent cutting edge clinical trials with the new standard of care in first line small cell lung cancer. Every contribution sheds light on new science and better therapies for patients suffering from cancer. By providing datasets, you keep the platform robust and enable investigators to continue to make groundbreaking discoveries for the benefit of cancer patients.
Welcome to the new Project Data Sphere website!
If you're looking to access or contribute data, the new address is data.projectdatasphere.org.